MedPath

Phentermine Hydrochloride

These highlights do not include all the information needed to use phentermine hydrochloride tablets USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets USP. PHENTERMINE Hydrochloride Tablets USP CIV for oral use Initial U.S. Approval: 1959

Approved
Approval ID

735d1c5f-ee7e-45c7-9f1a-458577498173

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2015

Manufacturers
FDA

Blenheim Pharmacal, Inc.

DUNS: 171434587

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phentermine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10544-552
Application NumberANDA040526
Product Classification
M
Marketing Category
C73584
G
Generic Name
Phentermine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateMarch 30, 2015
FDA Product Classification

INGREDIENTS (6)

crospovidoneInactive
Code: 68401960MK
Classification: IACT
calcium phosphate, dibasic, dihydrateInactive
Code: O7TSZ97GEP
Classification: IACT
Phentermine HydrochlorideActive
Quantity: 30 mg in 1 1
Code: 0K2I505OTV
Classification: ACTIM
FD&C Blue No. 1Inactive
Code: H3R47K3TBD
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
povidonesInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Phentermine Hydrochloride - FDA Drug Approval Details